{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T19:07:03Z","timestamp":1793387223499,"version":"4.5.0"},"reference-count":128,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T00:00:00Z","timestamp":1745971200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["RCCPDB- Nov21\/100008"],"award-info":[{"award-number":["RCCPDB- Nov21\/100008"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009253","name":"European Association for the Study of the Liver","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009253","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal-of-hepatology.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.jhep.2025.04.028","type":"journal-article","created":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T23:29:57Z","timestamp":1746055797000},"page":"971-981","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Hepatocellular carcinoma in people living with HIV"],"prefix":"10.1016","volume":"83","author":[{"given":"Claudia A.M.","family":"Fulgenzi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0209-4245","authenticated-orcid":false,"given":"Alessia","family":"Dalla Pria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9365-2160","authenticated-orcid":false,"given":"Alberto Giovanni","family":"Leone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ciro","family":"Celsa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0946-3859","authenticated-orcid":false,"given":"Giuseppe","family":"Cabibbo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernhard","family":"Scheiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7260-532X","authenticated-orcid":false,"given":"Matthias","family":"Pinter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"D\u2019Alessio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-0447-0448","authenticated-orcid":false,"given":"Yiran","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3520-4180","authenticated-orcid":false,"given":"Norbert","family":"Brau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4077-6351","authenticated-orcid":false,"given":"Mark","family":"Bower","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3529-0103","authenticated-orcid":false,"given":"David James","family":"Pinato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.jhep.2025.04.028_bib1","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1056\/NEJMra1615896","article-title":"HIV-associated cancers and related diseases","volume":"378","author":"Yarchoan","year":"2018","journal-title":"N Engl J Med"},{"issue":"9772","key":"10.1016\/j.jhep.2025.04.028_bib2","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1016\/S0140-6736(10)62001-6","article-title":"Increasing burden of liver disease in patients with HIV infection","volume":"377","author":"Joshi","year":"2011","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.jhep.2025.04.028_bib3","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1200\/JCO.18.00885","article-title":"Influence of HIV infection on the natural history of hepatocellular carcinoma: results from a global multicohort study","volume":"37","author":"Pinato","year":"2019","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.jhep.2025.04.028_bib4","first-page":"87","article-title":"HIV and liver disease","volume":"25","author":"Navarro","year":"2022","journal-title":"AIDS Rev"},{"issue":"1","key":"10.1016\/j.jhep.2025.04.028_bib5","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1093\/jnci\/djad172","article-title":"Risk of hepatocellular carcinoma in people with HIV in the United States, 2001-2019","volume":"116","author":"McGee-Avila","year":"2024","journal-title":"J Natl Cancer Inst"},{"issue":"16","key":"10.1016\/j.jhep.2025.04.028_bib6","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1097\/QAD.0b013e32831103ad","article-title":"Influence of HIV-related immunodeficiency on the risk of hepatocellular carcinoma","volume":"22","author":"Clifford","year":"2008","journal-title":"AIDS"},{"issue":"3","key":"10.1016\/j.jhep.2025.04.028_bib7","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/jvh.13217","article-title":"Prevalence and burden of HBV co-infection among people living with HIV: a global systematic review and meta-analysis","volume":"27","author":"Platt","year":"2020","journal-title":"J Viral Hepat"},{"issue":"2","key":"10.1016\/j.jhep.2025.04.028_bib8","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16020259","article-title":"MASLD and the development of HCC: pathogenesis and therapeutic challenges","volume":"16","author":"Phoolchund","year":"2024","journal-title":"Cancers (Basel)"},{"issue":"3","key":"10.1016\/j.jhep.2025.04.028_bib9","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.jhep.2024.04.031","article-title":"European Association for the Study of Obesity. EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)","volume":"81","year":"2024","journal-title":"J Hepatol"},{"issue":"6","key":"10.1016\/j.jhep.2025.04.028_bib10","doi-asserted-by":"crossref","first-page":"5965","DOI":"10.3390\/cimb46060356","article-title":"MASLD-related HCC: a comprehensive review of the trends, pathophysiology, tumor microenvironment, surveillance, and treatment options","volume":"46","author":"Shi","year":"2024","journal-title":"Curr Issues Mol Biol"},{"issue":"2","key":"10.1016\/j.jhep.2025.04.028_bib11","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1097\/QAD.0000000000000922","article-title":"Prevalence of non-HIV cancer risk factors in persons living with HIV\/AIDS: a meta-analysis","volume":"30","author":"Park","year":"2016","journal-title":"AIDS"},{"issue":"10","key":"10.1016\/j.jhep.2025.04.028_bib12","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1093\/cid\/ciu097","article-title":"Relationship between alcohol use categories and noninvasive markers of advanced hepatic fibrosis in HIV-infected, chronic hepatitis C virus-infected, and uninfected patients","volume":"58","author":"Lim","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.jhep.2025.04.028_bib13","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.ejca.2003.08.025","article-title":"Prevalence of liver tumours in HIV-1 tat-transgenic mice treated with urethane","volume":"40","author":"Altavilla","year":"2004","journal-title":"Eur J Cancer"},{"issue":"3","key":"10.1016\/j.jhep.2025.04.028_bib14","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1053\/j.gastro.2008.01.005","article-title":"HIV increases HCV replication in a TGF-beta1-dependent manner","volume":"134","author":"Lin","year":"2008","journal-title":"Gastroenterology"},{"issue":"11","key":"10.1016\/j.jhep.2025.04.028_bib15","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/j.cmi.2015.07.009","article-title":"Immunodeficiency-associated viral oncogenesis","volume":"21","author":"Pierangeli","year":"2015","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"10.1016\/j.jhep.2025.04.028_bib16","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1097\/QAI.0b013e3182a685dc","article-title":"Incidence of hepatocellular carcinoma in HIV-infected patients with cirrhosis: a prospective study","volume":"65","author":"Montes Ramirez","year":"2014","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"7","key":"10.1016\/j.jhep.2025.04.028_bib17","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1093\/jnci\/djz214","article-title":"HIV RNA, CD4+ percentage, and risk of hepatocellular carcinoma by cirrhosis status","volume":"112","author":"Torgersen","year":"2020","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"10.1016\/j.jhep.2025.04.028_bib18","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/imr.12823","article-title":"T-cell exhaustion in HIV infection","volume":"292","author":"Fenwick","year":"2019","journal-title":"Immunol Rev"},{"issue":"4","key":"10.1016\/j.jhep.2025.04.028_bib19","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-004564","article-title":"Patients with HIV-associated cancers have evidence of increased T cell dysfunction and exhaustion prior to cancer diagnosis","volume":"10","author":"Chaudhary","year":"2022","journal-title":"J Immunother Cancer"},{"issue":"1","key":"10.1016\/j.jhep.2025.04.028_bib20","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1038\/s41467-019-08798-7","article-title":"PD-1 blockade potentiates HIV latency reversal ex vivo in CD4(+) T cells from ART-suppressed individuals","volume":"10","author":"Fromentin","year":"2019","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.jhep.2025.04.028_bib21","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/QAI.0000000000002094","article-title":"Determinants of liver complications among HIV\/hepatitis B virus-coinfected patients","volume":"82","author":"Lo Re","year":"2019","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"1","key":"10.1016\/j.jhep.2025.04.028_bib22","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1097\/COH.0000000000000335","article-title":"Hepatocellular carcinoma in patients with HIV","volume":"12","author":"Dika","year":"2017","journal-title":"Curr Opin HIV AIDS"},{"issue":"6","key":"10.1016\/j.jhep.2025.04.028_bib23","doi-asserted-by":"crossref","first-page":"9184","DOI":"10.3390\/ijms15069184","article-title":"Molecular mechanisms of liver fibrosis in HIV\/HCV coinfection","volume":"15","author":"Mastroianni","year":"2014","journal-title":"Int J Mol Sci"},{"issue":"3","key":"10.1016\/j.jhep.2025.04.028_bib24","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.jhep.2013.04.029","article-title":"Impaired CD4(+) T cell stimulation of NK cell anti-fibrotic activity may contribute to accelerated liver fibrosis progression in HIV\/HCV patients","volume":"59","author":"Glassner","year":"2013","journal-title":"J Hepatol"},{"issue":"11","key":"10.1016\/j.jhep.2025.04.028_bib25","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1097\/QAD.0b013e3283471d10","article-title":"Microbial translocation predicts disease progression of HIV-infected antiretroviral-naive patients with high CD4+ cell count","volume":"25","author":"Marchetti","year":"2011","journal-title":"AIDS"},{"issue":"2","key":"10.1016\/j.jhep.2025.04.028_bib26","first-page":"147","article-title":"Metabolic syndrome, insulin resistance and adiponectin level in patients with chronic hepatitis C","volume":"17","author":"Grigorescu","year":"2008","journal-title":"J Gastrointestin Liver Dis"},{"issue":"3","key":"10.1016\/j.jhep.2025.04.028_bib27","doi-asserted-by":"crossref","first-page":"549","DOI":"10.3851\/IMP1988","article-title":"Effects of ritonavir-boosted darunavir, atazanavir and lopinavir on adipose functions and insulin sensitivity in murine and human adipocytes","volume":"17","author":"Capel","year":"2012","journal-title":"Antivir Ther"},{"issue":"2","key":"10.1016\/j.jhep.2025.04.028_bib28","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1097\/QAI.0b013e3181c190f4","article-title":"Insulin sensitivity in multiple pathways is differently affected during zidovudine\/lamivudine-containing compared with NRTI-sparing combination antiretroviral therapy","volume":"53","author":"van Vonderen","year":"2010","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"6","key":"10.1016\/j.jhep.2025.04.028_bib29","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1097\/COH.0b013e32834bd365","article-title":"HIV\/hepatitis C coinfection natural history and disease progression","volume":"6","author":"Hernandez","year":"2011","journal-title":"Curr Opin HIV AIDS"},{"issue":"2","key":"10.1016\/j.jhep.2025.04.028_bib30","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.jhep.2013.09.022","article-title":"Liver fibrosis progression at autopsy in injecting drug users infected by hepatitis C: a longitudinal long-term cohort study","volume":"60","author":"Kielland","year":"2014","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2025.04.028_bib31","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.3389\/fimmu.2019.02525","article-title":"Liver-mediated adaptive immune tolerance","volume":"10","author":"Zheng","year":"2019","journal-title":"Front Immunol"},{"issue":"7","key":"10.1016\/j.jhep.2025.04.028_bib32","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.28930","article-title":"Persistent hepatitis B virus and HIV coinfections in dually humanized mice engrafted with human liver and immune system","volume":"95","author":"Hogan","year":"2023","journal-title":"J Med Virol"},{"issue":"13","key":"10.1016\/j.jhep.2025.04.028_bib33","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.152738","article-title":"Type I interferons and TGF-beta cooperate to induce liver fibrosis during HIV-1 infection under antiretroviral therapy","volume":"7","author":"Ahodantin","year":"2022","journal-title":"JCI Insight"},{"issue":"7","key":"10.1016\/j.jhep.2025.04.028_bib34","article-title":"Integrated phenotyping of the anti-cancer immune response in HIV-associated hepatocellular carcinoma","volume":"5","author":"Pinato","year":"2023","journal-title":"JHEP Rep"},{"issue":"11","key":"10.1016\/j.jhep.2025.04.028_bib35","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1111\/hiv.13542","article-title":"Major revision version 12.0 of the European AIDS Clinical Society guidelines 2023","volume":"24","author":"Ambrosioni","year":"2023","journal-title":"HIV Med"},{"issue":"2","key":"10.1016\/j.jhep.2025.04.028_bib36","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.jhep.2017.03.021","article-title":"EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection","volume":"67","year":"2017","journal-title":"J Hepatol"},{"issue":"4","key":"10.1016\/j.jhep.2025.04.028_bib37","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1002\/hep.29800","article-title":"Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance","volume":"67","author":"Terrault","year":"2018","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.jhep.2025.04.028_bib38","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1097\/00002030-199404000-00024","article-title":"Impaired response to recombinant hepatitis B vaccine in asymptomatic HIV-infected individuals","volume":"8","author":"Tayal","year":"1994","journal-title":"AIDS"},{"issue":"14","key":"10.1016\/j.jhep.2025.04.028_bib39","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1001\/jama.2011.351","article-title":"Safety and immunogenicity of 4 intramuscular double doses and 4 intradermal low doses vs standard hepatitis B vaccine regimen in adults with HIV-1: a randomized controlled trial","volume":"305","author":"Launay","year":"2011","journal-title":"JAMA"},{"issue":"9349","key":"10.1016\/j.jhep.2025.04.028_bib40","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1016\/S0140-6736(02)11913-1","article-title":"HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS)","volume":"360","author":"Thio","year":"2002","journal-title":"Lancet"},{"issue":"1 Suppl","key":"10.1016\/j.jhep.2025.04.028_bib41","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.1016\/j.jhep.2005.11.015","article-title":"Natural history of chronic hepatitis B in co-infected patients","volume":"44","author":"Puoti","year":"2006","journal-title":"J Hepatol"},{"issue":"4","key":"10.1016\/j.jhep.2025.04.028_bib42","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1086\/321909","article-title":"Influence of human immunodeficiency virus infection on the course of hepatitis C virus infection: a meta-analysis","volume":"33","author":"Graham","year":"2001","journal-title":"Clin Infect Dis"},{"issue":"15","key":"10.1016\/j.jhep.2025.04.028_bib43","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1097\/QAD.0b013e32830e6d51","article-title":"Natural history of hepatitis C virus infection in HIV-infected individuals and the impact of HIV in the era of highly active antiretroviral therapy: a meta-analysis","volume":"22","author":"Thein","year":"2008","journal-title":"AIDS"},{"issue":"1","key":"10.1016\/j.jhep.2025.04.028_bib44","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1093\/cid\/cix260","article-title":"Sofosbuvir and velpatasvir for the treatment of hepatitis C virus in patients coinfected with human immunodeficiency virus type 1: an open-label, phase 3 study","volume":"65","author":"Wyles","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"8","key":"10.1016\/j.jhep.2025.04.028_bib45","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1111\/liv.14537","article-title":"Global real-world evidence of sofosbuvir\/velpatasvir as simple, effective HCV treatment: analysis of 5552 patients from 12 cohorts","volume":"40","author":"Mangia","year":"2020","journal-title":"Liver Int"},{"issue":"7","key":"10.1016\/j.jhep.2025.04.028_bib46","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1093\/cid\/ciy220","article-title":"Efficacy and safety of glecaprevir\/pibrentasvir in patients coinfected with hepatitis C virus and human immunodeficiency virus type 1: the EXPEDITION-2 study","volume":"67","author":"Rockstroh","year":"2018","journal-title":"Clin Infect Dis"},{"issue":"8","key":"10.1016\/j.jhep.2025.04.028_bib47","doi-asserted-by":"crossref","first-page":"e319","DOI":"10.1016\/S2352-3018(15)00114-9","article-title":"Efficacy and safety of grazoprevir (MK-5172) and elbasvir (MK-8742) in patients with hepatitis C virus and HIV co-infection (C-EDGE CO-INFECTION): a non-randomised, open-label trial","volume":"2","author":"Rockstroh","year":"2015","journal-title":"Lancet HIV"},{"issue":"5","key":"10.1016\/j.jhep.2025.04.028_bib48","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1111\/hiv.12433","article-title":"Effect of alcohol consumption on all-cause and liver-related mortality among HIV-infected individuals","volume":"18","author":"Canan","year":"2017","journal-title":"HIV Med"},{"issue":"2","key":"10.1016\/j.jhep.2025.04.028_bib49","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.jhep.2007.09.010","article-title":"Mortality related to chronic hepatitis B and chronic hepatitis C in France: evidence for the role of HIV coinfection and alcohol consumption","volume":"48","author":"Marcellin","year":"2008","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.jhep.2025.04.028_bib50","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.jhep.2018.03.018","article-title":"EASL clinical practice guidelines: management of alcohol-related liver disease","volume":"69","year":"2018","journal-title":"J Hepatol"},{"issue":"6","key":"10.1016\/j.jhep.2025.04.028_bib51","article-title":"Metabolic dysfunction-associated steatotic liver disease in people living with HIV-limitations on antiretroviral therapy selection","volume":"14","author":"Kalopitas","year":"2024","journal-title":"Life (Basel)"},{"issue":"4","key":"10.1016\/j.jhep.2025.04.028_bib52","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/apt.13702","article-title":"Liver fibrosis and fatty liver in Asian HIV-infected patients","volume":"44","author":"Lui","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"issue":"7","key":"10.1016\/j.jhep.2025.04.028_bib53","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1016\/j.cgh.2023.01.001","article-title":"Prevalence and characteristics of nonalcoholic fatty liver disease and fibrosis in people living with HIV monoinfection: a systematic review and meta-analysis","volume":"21","author":"Kalligeros","year":"2023","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"5","key":"10.1016\/j.jhep.2025.04.028_bib54","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.bpg.2014.08.008","article-title":"Surveillance for hepatocellular carcinoma","volume":"28","author":"Sherman","year":"2014","journal-title":"Best Pract Res Clin Gastroenterol"},{"issue":"9","key":"10.1016\/j.jhep.2025.04.028_bib55","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.35066","article-title":"Survival outcomes among patients with hepatocellular carcinoma in a large integrated US health system","volume":"7","author":"Yilma","year":"2024","journal-title":"JAMA Netw Open"},{"issue":"1","key":"10.1016\/j.jhep.2025.04.028_bib56","article-title":"Prognostication and risk factor stratification for survival of patients with hepatocellular carcinoma: a nationwide big data analysis","volume":"13","author":"Choi","year":"2023","journal-title":"Sci Rep"},{"issue":"6","key":"10.1016\/j.jhep.2025.04.028_bib57","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"10.1016\/j.jhep.2025.04.028_bib58","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.37512","article-title":"Trends in hepatocellular carcinoma incidence and risk among persons with HIV in the US and Canada, 1996-2015","volume":"4","author":"Sun","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"4","key":"10.1016\/j.jhep.2025.04.028_bib59","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/S0002-9343(96)00197-0","article-title":"Cost-effectiveness of screening for detection of small hepatocellular carcinoma in western patients with Child-Pugh class A cirrhosis","volume":"101","author":"Sarasin","year":"1996","journal-title":"Am J Med"},{"issue":"4","key":"10.1016\/j.jhep.2025.04.028_bib60","first-page":"547","article-title":"HIV and liver disease: a comprehensive update","volume":"30","author":"Sherman","year":"2022","journal-title":"Top Antivir Med"},{"issue":"5 Suppl 1","key":"10.1016\/j.jhep.2025.04.028_bib61","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1053\/j.gastro.2004.09.014","article-title":"Hepatocellular carcinoma in cirrhosis: incidence and risk factors","volume":"127","author":"Fattovich","year":"2004","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.jhep.2025.04.028_bib62","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.jhep.2024.08.028","article-title":"EASL Clinical Practice Guidelines on the management of hepatocellular carcinoma","volume":"82","year":"2025","journal-title":"J Hepatol"},{"issue":"6","key":"10.1016\/j.jhep.2025.04.028_bib63","doi-asserted-by":"crossref","first-page":"665","DOI":"10.3748\/wjg.v28.i6.665","article-title":"Validation of the PAGE-B score to predict hepatocellular carcinoma risk in caucasian chronic hepatitis B patients on treatment","volume":"28","author":"Gokcen","year":"2022","journal-title":"World J Gastroenterol"},{"issue":"5","key":"10.1016\/j.jhep.2025.04.028_bib64","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.jhep.2022.12.029","article-title":"External validation of the PAGE-B score for HCC risk prediction in people living with HIV\/HBV coinfection","volume":"78","author":"Surial","year":"2023","journal-title":"J Hepatol"},{"issue":"9","key":"10.1016\/j.jhep.2025.04.028_bib65","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1093\/jac\/dky234","article-title":"Sustained virological response to direct-acting antiviral regimens reduces the risk of hepatocellular carcinoma in HIV\/HCV-coinfected patients with cirrhosis","volume":"73","author":"Merchante","year":"2018","journal-title":"J Antimicrob Chemother"},{"issue":"2","key":"10.1016\/j.jhep.2025.04.028_bib66","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1093\/cid\/ciae359","article-title":"Early detection of cancer and precancerous lesions in persons with HIV through a comprehensive cancer screening protocol","volume":"80","author":"Gutierrez","year":"2025","journal-title":"Clin Infect Dis"},{"issue":"8","key":"10.1016\/j.jhep.2025.04.028_bib67","doi-asserted-by":"crossref","first-page":"986","DOI":"10.6004\/jnccn.2018.0066","article-title":"Cancer in people living with HIV, version 1.2018, NCCN clinical practice guidelines in oncology","volume":"16","author":"Reid","year":"2018","journal-title":"J Natl Compr Canc Netw"},{"issue":"2","key":"10.1016\/j.jhep.2025.04.028_bib68","doi-asserted-by":"crossref","first-page":"171","DOI":"10.6004\/jnccn.2019.0008","article-title":"AIDS-related Kaposi sarcoma, version 2.2019, NCCN clinical practice guidelines in oncology","volume":"17","author":"Reid","year":"2019","journal-title":"J Natl Compr Canc Netw"},{"issue":"3","key":"10.1016\/j.jhep.2025.04.028_bib69","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.jhep.2021.11.018","article-title":"BCLC strategy for prognosis prediction and treatment recommendation: the 2022 update","volume":"76","author":"Reig","year":"2022","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.jhep.2025.04.028_bib70","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3390\/idr14010006","article-title":"Loco-regional treatments for hepatocellular carcinoma in people living with HIV","volume":"14","author":"Micali","year":"2022","journal-title":"Infect Dis Rep"},{"issue":"1","key":"10.1016\/j.jhep.2025.04.028_bib71","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1038\/s41598-020-80311-3","article-title":"Outcome of TACE treatment in HIV infected patients with hepatocellular carcinoma","volume":"11","author":"Kong","year":"2021","journal-title":"Sci Rep"},{"issue":"5","key":"10.1016\/j.jhep.2025.04.028_bib72","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1007\/s00268-009-9969-6","article-title":"Human immunodeficiency disease: how should it affect surgical decision making?","volume":"33","author":"Madiba","year":"2009","journal-title":"World J Surg"},{"key":"10.1016\/j.jhep.2025.04.028_bib73","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.18203\/2349-2902.isj20232653","article-title":"A review of the role of liver resection in the treatment of human immuno-deficiency virus-positive patients with hepatocellular carcinoma","volume":"10","author":"Coelho MBT","year":"2023","journal-title":"Int Surg J"},{"issue":"3","key":"10.1016\/j.jhep.2025.04.028_bib74","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1097\/QAI.0000000000002561","article-title":"Comparative analysis of presentation and outcome after liver resection of patients with hepatocellular carcinoma with and without HIV","volume":"86","author":"Zhao","year":"2021","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"6","key":"10.1016\/j.jhep.2025.04.028_bib75","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15061653","article-title":"Survival in people living with HIV with or without recurrence of hepatocellular carcinoma after invasive therapy","volume":"15","author":"Bertoni","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"9","key":"10.1016\/j.jhep.2025.04.028_bib76","doi-asserted-by":"crossref","first-page":"3851","DOI":"10.4251\/wjgo.v16.i9.3851","article-title":"Retrospective analysis of patients with hepatocellular carcinoma complicated with human immunodeficiency virus infection after hepatectomy","volume":"16","author":"Lu","year":"2024","journal-title":"World J Gastrointest Oncol"},{"key":"10.1016\/j.jhep.2025.04.028_bib77","series-title":"Perioperative care in adults with HIV. New York state department of health AIDS Institute clinical guidelines. Baltimore (MD)","author":"Shin","year":"2024"},{"issue":"11","key":"10.1016\/j.jhep.2025.04.028_bib78","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJM199603143341104","article-title":"Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis","volume":"334","author":"Mazzaferro","year":"1996","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.jhep.2025.04.028_bib79","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1053\/j.gastro.2017.09.025","article-title":"Metroticket 2.0 model for analysis of competing risks of death after liver transplantation for hepatocellular carcinoma","volume":"154","author":"Mazzaferro","year":"2018","journal-title":"Gastroenterology"},{"issue":"43","key":"10.1016\/j.jhep.2025.04.028_bib80","doi-asserted-by":"crossref","first-page":"12311","DOI":"10.3748\/wjg.v21.i43.12311","article-title":"Role of liver transplantation in human immunodeficiency virus positive patients","volume":"21","author":"Joshi","year":"2015","journal-title":"World J Gastroenterol"},{"issue":"2","key":"10.1016\/j.jhep.2025.04.028_bib81","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1097\/01.TP.0000075973.73064.A6","article-title":"Kidney and liver transplantation in human immunodeficiency virus-infected patients: a pilot safety and efficacy study","volume":"76","author":"Stock","year":"2003","journal-title":"Transplantation"},{"key":"10.1016\/j.jhep.2025.04.028_bib82","doi-asserted-by":"crossref","DOI":"10.1016\/j.dld.2025.02.014","article-title":"Liver transplantation in people living with HIV: an Italian nationwide survey focusing on hepatocellular carcinoma and oncologic recurrences","author":"Visco-Comandini","year":"2025","journal-title":"Dig Liver Dis"},{"issue":"10","key":"10.1016\/j.jhep.2025.04.028_bib83","article-title":"Liver transplantation in people living with HIV: still an experimental procedure or standard of care?","volume":"13","author":"Lynch","year":"2023","journal-title":"Life (Basel)"},{"issue":"2","key":"10.1016\/j.jhep.2025.04.028_bib84","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.dld.2022.05.001","article-title":"Similar survival but higher and delayed hepatocellular carcinoma recurrence in HIV-positive compared to negative cirrhotics undergoing liver transplantation","volume":"55","author":"Rossotti","year":"2023","journal-title":"Dig Liver Dis"},{"issue":"18","key":"10.1016\/j.jhep.2025.04.028_bib85","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13184727","article-title":"Liver transplantation for HCC in HIV-infected patients: long-term single-center experience","volume":"13","author":"Guerrini","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"5","key":"10.1016\/j.jhep.2025.04.028_bib86","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1634\/theoncologist.2012-0255","article-title":"Multicenter Italian experience in liver transplantation for hepatocellular carcinoma in HIV-infected patients","volume":"18","author":"Di Benedetto","year":"2013","journal-title":"Oncologist"},{"issue":"2","key":"10.1016\/j.jhep.2025.04.028_bib87","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1002\/hep.28321","article-title":"Human immunodeficiency virus infection does not worsen prognosis of liver transplantation for hepatocellular carcinoma","volume":"63","author":"Aguero","year":"2016","journal-title":"Hepatology"},{"issue":"8","key":"10.1016\/j.jhep.2025.04.028_bib88","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/j.hpb.2019.01.001","article-title":"Long term outcomes of patients transplanted for hepatocellular carcinoma with human immunodeficiency virus infection","volume":"21","author":"Eman","year":"2019","journal-title":"HPB (Oxford)"},{"key":"10.1016\/j.jhep.2025.04.028_bib89","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.trim.2016.06.001","article-title":"Influence of immune activation on the risk of allograft rejection in human immunodeficiency virus-infected kidney transplant recipients","volume":"38","author":"Lorio","year":"2016","journal-title":"Transpl Immunol"},{"issue":"5","key":"10.1016\/j.jhep.2025.04.028_bib90","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1016\/j.athoracsur.2020.06.120","article-title":"Heart transplantation survival outcomes of HIV positive and negative recipients","volume":"111","author":"Doberne","year":"2021","journal-title":"Ann Thorac Surg"},{"issue":"6","key":"10.1016\/j.jhep.2025.04.028_bib91","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.13534","article-title":"Higher rates of rejection in HIV-infected kidney transplant recipients on ritonavir-boosted protease inhibitors: 3-year follow-up study","volume":"33","author":"Rollins","year":"2019","journal-title":"Clin Transpl"},{"issue":"9","key":"10.1016\/j.jhep.2025.04.028_bib92","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.13499","article-title":"Solid organ transplantation in the HIV-infected patient: guidelines from the American society of transplantation infectious diseases community of practice","volume":"33","author":"Blumberg","year":"2019","journal-title":"Clin Transpl"},{"issue":"1","key":"10.1016\/j.jhep.2025.04.028_bib93","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/01.TP.0000165111.09687.4E","article-title":"Cyclosporine pharmacokinetics and dosing modifications in human immunodeficiency virus-infected liver and kidney transplant recipients","volume":"80","author":"Frassetto","year":"2005","journal-title":"Transplantation"},{"issue":"7","key":"10.1016\/j.jhep.2025.04.028_bib94","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/S1470-2045(24)00189-X","article-title":"Cancer risk in people living with HIV and solid organ transplant recipients: a systematic review and meta-analysis","volume":"25","author":"Jin","year":"2024","journal-title":"Lancet Oncol"},{"issue":"14","key":"10.1016\/j.jhep.2025.04.028_bib95","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1016\/j.ejca.2007.07.015","article-title":"Risk of cancer following immunosuppression in organ transplant recipients and in HIV-positive individuals in southern Europe","volume":"43","author":"Serraino","year":"2007","journal-title":"Eur J Cancer"},{"issue":"11","key":"10.1016\/j.jhep.2025.04.028_bib96","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/j.cgh.2012.08.010","article-title":"Presentation, treatment, and clinical outcomes of patients with hepatocellular carcinoma, with and without human immunodeficiency virus infection","volume":"10","author":"Yopp","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"5","key":"10.1016\/j.jhep.2025.04.028_bib97","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1097\/QAI.0b013e31826ebdc7","article-title":"Standardized care management ensures similar survival rates in HIV-positive and HIV-negative patients with hepatocellular carcinoma","volume":"61","author":"Lim","year":"2012","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"4","key":"10.1016\/j.jhep.2025.04.028_bib98","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.jhep.2007.06.010","article-title":"Presentation and outcome of hepatocellular carcinoma in HIV-infected patients: a U.S.-Canadian multicenter study","volume":"47","author":"Brau","year":"2007","journal-title":"J Hepatol"},{"issue":"9","key":"10.1016\/j.jhep.2025.04.028_bib99","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1634\/theoncologist.2010-0400","article-title":"Hepatocellular carcinoma in HIV-infected patients: check early, treat hard","volume":"16","author":"Berretta","year":"2011","journal-title":"Oncologist"},{"issue":"17","key":"10.1016\/j.jhep.2025.04.028_bib100","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1097\/00002030-200411190-00009","article-title":"Hepatocellular carcinoma in HIV-infected patients: epidemiological features, clinical presentation and outcome","volume":"18","author":"Puoti","year":"2004","journal-title":"AIDS"},{"issue":"1","key":"10.1016\/j.jhep.2025.04.028_bib101","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/liv.13921","article-title":"Prognostic factors of survival in HIV\/HCV co-infected patients with hepatocellular carcinoma: the CARCINOVIC Cohort","volume":"39","author":"Gelu-Simeon","year":"2019","journal-title":"Liver Int"},{"issue":"6","key":"10.1016\/j.jhep.2025.04.028_bib102","first-page":"422","article-title":"Direct-acting antivirals for HIV\/HCV Co-infected individuals: as good as it gets?","volume":"15","author":"Bruno","year":"2017","journal-title":"Curr HIV Res"},{"issue":"4","key":"10.1016\/j.jhep.2025.04.028_bib103","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.jhep.2020.11.026","article-title":"Systemic treatment of HCC in special populations","volume":"74","author":"Rimassa","year":"2021","journal-title":"J Hepatol"},{"issue":"9","key":"10.1016\/j.jhep.2025.04.028_bib104","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2021.101153","article-title":"Hepatocellular cancer therapy in patients with HIV infection: disparities in cancer care, trials enrolment, and cancer-related research","volume":"14","author":"Negri","year":"2021","journal-title":"Transl Oncol"},{"issue":"1","key":"10.1016\/j.jhep.2025.04.028_bib105","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1097\/QAD.0000000000001293","article-title":"Real-life experience with sorafenib for the treatment of hepatocellular carcinoma in HIV-infected patients","volume":"31","author":"Merchante","year":"2017","journal-title":"AIDS"},{"issue":"10126","key":"10.1016\/j.jhep.2025.04.028_bib106","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/S0140-6736(18)30207-1","article-title":"Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial","volume":"391","author":"Kudo","year":"2018","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.jhep.2025.04.028_bib107","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1056\/NEJMoa1717002","article-title":"Cabozantinib in patients with advanced and progressing hepatocellular carcinoma","volume":"379","author":"Abou-Alfa","year":"2018","journal-title":"N Engl J Med"},{"issue":"10064","key":"10.1016\/j.jhep.2025.04.028_bib108","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0140-6736(16)32453-9","article-title":"Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"389","author":"Bruix","year":"2017","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.jhep.2025.04.028_bib109","doi-asserted-by":"crossref","first-page":"866","DOI":"10.2174\/1389200221999200918141239","article-title":"Current treatment options for HCC: from pharmacokinetics to efficacy and adverse events in liver cirrhosis","volume":"21","author":"Galati","year":"2020","journal-title":"Curr Drug Metab"},{"key":"10.1016\/j.jhep.2025.04.028_bib110","doi-asserted-by":"crossref","first-page":"241","DOI":"10.2147\/JHC.S270532","article-title":"A comparison of lenvatinib versus sorafenib in the first-line treatment of unresectable hepatocellular carcinoma: selection criteria to guide physician's choice in a new therapeutic scenario","volume":"8","author":"Dipasquale","year":"2021","journal-title":"J Hepatocell Carcinoma"},{"issue":"5","key":"10.1016\/j.jhep.2025.04.028_bib111","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1634\/theoncologist.2016-0486","article-title":"A phase ib study of sorafenib (BAY 43-9006) in patients with Kaposi sarcoma","volume":"22","author":"Uldrick","year":"2017","journal-title":"Oncologist"},{"key":"10.1016\/j.jhep.2025.04.028_bib112","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1242741","article-title":"Case Report: lenvatinib for the treatment of recurrent hepatocellular carcinoma in people living with HIV: a report of two cases","volume":"13","author":"Morsica","year":"2023","journal-title":"Front Oncol"},{"issue":"24","key":"10.1016\/j.jhep.2025.04.028_bib113","doi-asserted-by":"crossref","first-page":"5038","DOI":"10.1158\/1078-0432.CCR-23-1142","article-title":"Phase I trial of the multi-kinase inhibitor cabozantinib, a CYP3A4 substrate, plus CYP3A4-interacting antiretroviral therapy in people living with HIV and cancer (AMC-087)","volume":"29","author":"Haigentz","year":"2023","journal-title":"Clin Cancer Res"},{"issue":"20","key":"10.1016\/j.jhep.2025.04.028_bib114","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1056\/NEJMoa1915745","article-title":"Atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma","volume":"382","author":"Finn","year":"2020","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.jhep.2025.04.028_bib115","doi-asserted-by":"crossref","first-page":"493","DOI":"10.2165\/11531280-000000000-00000","article-title":"Clinical pharmacokinetics of therapeutic monoclonal antibodies","volume":"49","author":"Keizer","year":"2010","journal-title":"Clin Pharmacokinet"},{"issue":"9","key":"10.1016\/j.jhep.2025.04.028_bib116","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1001\/jamaoncol.2019.2244","article-title":"Assessment of the safety of pembrolizumab in patients with HIV and advanced cancer-A phase 1 study","volume":"5","author":"Uldrick","year":"2019","journal-title":"JAMA Oncol"},{"issue":"21","key":"10.1016\/j.jhep.2025.04.028_bib117","doi-asserted-by":"crossref","first-page":"3712","DOI":"10.1200\/JCO.22.02459","article-title":"Safety and activity of immune checkpoint inhibitors in people living with HIV and cancer: a real-world report from the cancer therapy using checkpoint inhibitors in people living with HIV-international (CATCH-IT) consortium","volume":"41","author":"El","year":"2023","journal-title":"J Clin Oncol"},{"issue":"3_suppl","key":"10.1016\/j.jhep.2025.04.028_bib118","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1200\/JCO.2024.42.3_suppl.442","article-title":"Efficacy of immune checkpoint inhibitors in patients with HIV-associated unresectable HCC (uHCC): propensity-score matched analyses from two international consortia","volume":"42","author":"Fulgenzi","year":"2024","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.jhep.2025.04.028_bib119","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1200\/JCO.24.00640","article-title":"Cancer immunotherapy trials network 12: pembrolizumab in HIV-associated Kaposi sarcoma","volume":"43","author":"Lurain","year":"2025","journal-title":"J Clin Oncol"},{"issue":"7","key":"10.1016\/j.jhep.2025.04.028_bib120","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1001\/jamaoncol.2020.0465","article-title":"Assessment of the feasibility and safety of durvalumab for treatment of solid tumors in patients with HIV-1 infection: the phase 2 DURVAST study","volume":"6","author":"Gonzalez-Cao","year":"2020","journal-title":"JAMA Oncol"},{"issue":"6","key":"10.1016\/j.jhep.2025.04.028_bib121","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1097\/QAD.0000000000002815","article-title":"Worldwide relative smoking prevalence among people living with and without HIV","volume":"35","author":"Johnston","year":"2021","journal-title":"AIDS"},{"issue":"2","key":"10.1016\/j.jhep.2025.04.028_bib122","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s12160-016-9822-8","article-title":"Extending the minority stress model to incorporate HIV-positive gay and bisexual men\u2019s experiences: a longitudinal examination of mental health and sexual risk behavior","volume":"51","author":"Rendina","year":"2017","journal-title":"Ann Behav Med"},{"issue":"11","key":"10.1016\/j.jhep.2025.04.028_bib123","doi-asserted-by":"crossref","first-page":"2992","DOI":"10.1007\/s10461-019-02629-y","article-title":"Age, sex, race, ethnicity, sexual orientation: intersectionality of marginalized-group identities and enacted HIV-related stigma among people living with HIV in Florida","volume":"23","author":"Algarin","year":"2019","journal-title":"AIDS Behav"},{"issue":"33","key":"10.1016\/j.jhep.2025.04.028_bib124","doi-asserted-by":"crossref","first-page":"3737","DOI":"10.1200\/JCO.2017.73.7916","article-title":"Broadening eligibility criteria to make clinical trials more representative: American society of clinical oncology and Friends of cancer research joint research statement","volume":"35","author":"Kim","year":"2017","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.jhep.2025.04.028_bib125","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.ijrobp.2023.01.045","article-title":"Improving cancer care for people living with HIV: a qualitative study of provider knowledge, attitudes, and practice","volume":"116","author":"Henry","year":"2023","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.jhep.2025.04.028_bib126","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1016\/S1473-3099(19)30524-9","article-title":"Tuberculosis, HIV, and viral hepatitis diagnostics in eastern Europe and central Asia: high time for integrated and people-centred services","volume":"20","author":"Dara","year":"2020","journal-title":"Lancet Infect Dis"},{"issue":"11","key":"10.1016\/j.jhep.2025.04.028_bib127","doi-asserted-by":"crossref","first-page":"ofaa483","DOI":"10.1093\/ofid\/ofaa483","article-title":"Prevalence and factors associated with liver fibrosis among adult HIV-infected patients attending urban and rural care clinics in Uganda","volume":"7","author":"Wekesa","year":"2020","journal-title":"Open Forum Infect Dis"},{"issue":"1","key":"10.1016\/j.jhep.2025.04.028_bib128","doi-asserted-by":"crossref","DOI":"10.7448\/IAS.20.1.21424","article-title":"Alcohol use, viral hepatitis and liver fibrosis among HIV-positive persons in West Africa: a cross-sectional study","volume":"19","author":"Jaquet","year":"2017","journal-title":"J Int AIDS Soc"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827825002879?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827825002879?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T08:40:30Z","timestamp":1774860030000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827825002879"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":128,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S0168827825002879"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2025.04.028","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hepatocellular carcinoma in people living with HIV","name":"articletitle","label":"Article Title"},{"value":"Journal of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2025.04.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V. on behalf of European Association for the Study of the Liver.","name":"copyright","label":"Copyright"}]}}